Division of Trauma and Acute Care Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medical College, National Cheng Kung University, Tainan, Taiwan.
Division of General Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medical College, National Cheng Kung University, Tainan, Taiwan.
Surg Endosc. 2018 Oct;32(10):4314-4320. doi: 10.1007/s00464-018-6287-9. Epub 2018 Jun 29.
Although laparoscopic hepatectomy has been proven to be safe and reliable, the influence of tumor size on the feasibility of laparoscopic left lateral segmentectomy (LLLS) is unclear. We retrospectively reviewed our surgical results focusing on hepatic tumor located in the left lateral segment.
From January 2003 to June 2016, patients who underwent left lateral segmentectomy were retrospectively reviewed, and data were collected on patient characteristics, peri-operative outcomes, and pathologic results. Patients with intrahepatic stone, cystic lesion, or unmeasurable tumor size were excluded. The continuous variables were compared using the Mann-Whitney U test and categorical variables using the Chi square or Fisher's exact test. The overall and disease-free survival rates were computed using the Kaplan-Meier method and compared using the log-rank test.
A total of 103 patients were enrolled for analysis. Among the patients with tumors larger than 5 cm in the left lateral segment, those who underwent laparoscopic surgery had significantly shorter hospital stay and larger resection margin than those who underwent open surgery. The surgical results of the patients who underwent LLLS were not significantly different from those of the patients with tumors larger than 5 cm. Specifically, the 5-year overall survival and disease-free survival rates of the patients with hepatocellular carcinoma (HCC) larger than 5 cm who underwent LLLS were comparable to those of the patients who underwent open left lateral segmentectomy.
LLLS is safe and also feasible for hepatic tumors larger than 5 cm. For HCCs larger than 5 cm, the laparoscopic approach yields satisfying oncologic outcomes as the open approach.
尽管腹腔镜肝切除术已被证明是安全可靠的,但肿瘤大小对腹腔镜左外叶切除术(LLLS)可行性的影响尚不清楚。我们回顾性分析了我们的手术结果,重点关注位于左外叶的肝肿瘤。
从 2003 年 1 月至 2016 年 6 月,回顾性分析接受左外叶切除术的患者,收集患者特征、围手术期结果和病理结果。排除肝内结石、囊性病变或无法测量肿瘤大小的患者。连续变量采用 Mann-Whitney U 检验比较,分类变量采用卡方或 Fisher 确切检验比较。采用 Kaplan-Meier 法计算总生存率和无病生存率,并采用对数秩检验比较。
共纳入 103 例患者进行分析。在肿瘤直径大于 5cm 的左外叶患者中,腹腔镜手术组的住院时间明显短于开腹手术组,切缘长度大于开腹手术组。肿瘤直径大于 5cm 的患者行 LLLS 的手术结果与肿瘤直径大于 5cm 的患者无显著差异。具体来说,肿瘤直径大于 5cm 的肝细胞癌(HCC)患者行 LLLS 的 5 年总生存率和无病生存率与开腹左外叶切除术相似。
LLLS 是安全的,对于直径大于 5cm 的肝肿瘤也是可行的。对于直径大于 5cm 的 HCC,腹腔镜方法的肿瘤学结果与开腹方法相当。